Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Leuk Lymphoma. 2016 Jan 14;57(9):2212–2215. doi: 10.3109/10428194.2015.1129536

Table I.

Baseline Characteristics for Enrolled Patients (N = 15)

Characteristic N (%)
Age
Median (range) 59 (49–76)
Gender
Male : Female 10 : 5
Prior therapies
Median (range) 5 (1–14)
Prior nucleoside analog 13 (87)
Prior allogeneic stem cell transplant 1 (7)
Cytogenetic abnormalities
Normal 1 (7)
Trisomy 12 1 (7)
Deletion 11q 1 (7)
Deletions 17p 2 (14)
Complex 10 (67)
Treatment Delivery
Dose Level 1 (16 mg/m2) 5
Dose Level 2 (20 mg/m2) 3
Dose Level 3 (24 mg/m2) 7